Medical Properties Trust: A Battleground REIT Now Yielding 9.5%

Summary

  • More recently, Medical Properties Trust, Inc. has been beaten down by short sellers, which has caused shares to massively underperform REIT peers.
  • Given these new facts, iREIT is downgrading shares from a Strong Buy to a Spec Buy and the quality rating decreases from 86 to 75.
  • Also, given the new quality score, we recommend that investors maintain responsible portfolio diversification.
  • This idea was discussed in more depth with members of my private investing community, iREIT on Alpha. Learn More »

face off robots

charles taylor

I’ve been covering Medical Properties Trust, Inc. (NYSE:MPW) for around a decade, and I haven’t always been bullish. As I explained in a Seeking Alpha article on April 15, 2013:

In 2018, I was still not sold on

Get My New Book For Free!

Join iREIT on Alpha today to get the most in-depth research that includes REITs, mREIT, Preferreds, BDCs, MLPs, ETFs, and we recently added Prop Tech SPACs to the lineup. Nothing to lose with our FREE 2-week trial.

And this offer includes a 2-Week FREE TRIAL plus my FREE book.

This article was written by

119.52K Followers

Brad Thomas has over 30 years of real estate investing experience and has acquired, developed, or brokered over $1B in commercial real estate transactions. He has been featured in Barron's, Bloomberg, Fox Business, and many other media outlets. He's the author of four books, including the latest, REITs For Dummies.

Brad, along with HOYA Capital, lead the investing group iREIT®+HOYA Capital. The service covers REITs, BDCs, MLPs, Preferreds, and other income-oriented alternatives. The team of analysts has a combined 100+ years of experience and includes a former hedge fund manager, due diligence officer, portfolio manager, PhD, military veteran, and advisor to a former U.S. President.

Note: Brad is also related to Nicholas Thomas who contributes to Seeking Alpha.

Learn more

Analyst’s Disclosure:I/we have a beneficial long position in the shares of MPW either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Author's note: Brad Thomas is a Wall Street writer, which means he's not always right with his predictions or recommendations. Since that also applies to his grammar, please excuse any typos you may find. Also, this article is free: Written and distributed only to assist in research while providing a forum for second-level thinking.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

About MPW Stock

SymbolLast Price% Chg
EPS
PE
Div Rate
Yield
Short Interest
Market Cap
Volume
Compare to Peers

More on MPW

Related Stocks

SymbolLast Price% Chg
MPW
--